Searched for
INTAS PHARMA
Cancer drug makers seek 50% price hike as platinum surge hits production viabilityLocal drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...06 Apr, 2026, 12.57 AM IST- Intas Pharma completes acquisition of UDENYCA biosimilar for $558 millionIntas Pharma finalized its acquisition of UDENYCA, a biosimilar to Neulasta, from Coherus Life Sciences for $558 million in December 2024. ...13 Aug, 2025, 10.38 AM IST
- Biosimilar brand buy to help Intas Pharma take on biggiesIn one of the biggest deals worldwide for a biosimilar brand, Ahmedabad-based Intas agreed to buy Udenyca-the brand name for medication peg...06 Jan, 2025, 11.51 PM IST
- Abu Dhabi Sovereign Fund to buy into Intas PharmaADIA, with assets under management worth $800 billion, has a wide exposure in India. Its major investments include Flipkart, Reliance Retai...27 Apr, 2022, 01.07 AM IST
- Intas low-balls Mallinckrodt unit bid to $1bn on legal fearsLast year, media reports mentioned that Intas had emerged as a strong contender to acquire Mallinckrodt unit in a deal estimated between $1...11 Jan, 2018, 11.41 AM IST
- Intas launches biosimilar Bevacizumab with aggressive pricingBiosimilar drugs are the follow on versions of biologic drugs which are composed of sugars, proteins, nucleic acids or complex combinations...04 Oct, 2017, 08.40 PM IST
- ChrysCapital sells 3% in Intas to Capital InternationalChrysCapital will continue to hold a 3% stake in Intas, making it the longest and probably the most successful private equity investment in...03 Apr, 2017, 12.33 PM IST
- Possible acquisition of Intas Pharma to be a positive for the company: Deepak ShenoyI believe that for them expansion through an inorganic route is perhaps the way to become the biggest Indian pharma company.22 Dec, 2015, 10.16 AM IST
- 15 doctors suspended for accepting junketsThe doctors’ regulatory body is also in the process of sending a letter to the Drug Controller General of India, urging it to warn and take...24 Feb, 2015, 04.58 AM IST
- Delhi High Court comes to Intas rescue, stops Arinna Lifescience for trademark violationDelhi High Court gave relief to Ahmedabad-based drug maker, Intas Pharmaceuticals, by granting an ex-parte injunction against the sale of V...30 Oct, 2014, 12.50 AM IST
- ChrysCapital to sell 10% in drug maker Intas Pharmaceuticals to Temasek for over $160 millionTemasek has bought 12.5% stake in Intas Pharmaceuticals, one of India's top 10 drug makers by sale, for a little over Rs 1,100 crore, peopl...03 Jun, 2014, 01.54 PM IST
- Temasek, two other PEs eye ChrysCapital’s 10 pc stake in Intas PharmaThree private equity funds are in independent talks to purchase rival ChrysCap’s stake Intas Pharmaceuticals for about $150 million or Rs 9...29 Jan, 2014, 04.00 AM IST
- Intas ex-employee objects to amalgamation planAn affidavit of objection challenging Intas' amalgamation was filed by Mani Iyer, a former executive director of Intas Biopharmaceuticals, ...11 Feb, 2013, 11.25 PM IST
- ChrysCapital, Blackstone and Advent Capital in race to buy stake in Intas Pharma for Rs 250 crore3 PE firms are vying for a minority stake in generic drugmaker Intas Pharmaceuticals, two people familiar with the development told ET.23 Apr, 2012, 03.29 AM IST
- Intas gets SEBI nod for IPO for raising Rs 800 croreIntas Pharmaceuticals has received SEBI clearance for its IPO. The issue was expected to hit the market in May, but Intas is still undecide...04 Aug, 2011, 08.41 PM IST
- Intas Biopharma in talks with Japanese co for outlicensingIntas Biopharmaceutical Ltd, a group company of the Rs 1,600-crore Intas Pharmaceuticals Ltd, would soon enter into an out-licensing and su...27 Sep, 2010, 12.24 PM IST
- Intas Pharma IPO to raise Rs 800 cr, fund acquisitionsIntas Pharma plans to raise Rs 750-800 cr through IPO that will help it raise fresh funds for acquisitions besides allowing PE investor Chr...06 Sep, 2010, 03.47 AM IST
Load More
